Adrenocortical Carcinoma Prognosis and Outlook

Adrenocortical carcinoma (ACC) is a rare cancer that starts in the outer layer of the adrenal glands. The prognosis, or outlook, for ACC depends on several factors, including the cancer's stage when diagnosed, its size, and whether it has spread. Early diagnosis and complete surgical removal offer the best chance for a positive outcome, though recurrence is possible.

What is Adrenocortical Carcinoma Prognosis and Outlook?

Adrenocortical carcinoma (ACC) is a rare and aggressive cancer that develops in the adrenal glands, which sit above your kidneys. The prognosis refers to the likely course of the disease and your chances of recovery, while the outlook describes the overall future prospects. For ACC, these depend heavily on how early the cancer is found and how much it has spread.

Adrenocortical carcinoma is a type of cancer that forms in the cortex, the outer part of the adrenal glands. These glands produce important hormones that regulate many body functions, such as metabolism, blood pressure, and stress response. When ACC develops, it can either produce too many hormones (functional tumor) or not produce hormones (non-functional tumor). The prognosis and outlook for ACC are highly individual and vary significantly among patients. Factors like the cancer's stage at diagnosis, the tumor's size, and whether it has spread to nearby tissues or distant parts of the body (metastasis) are crucial. The ability to completely remove the tumor through surgery also plays a major role in determining the long-term outlook. Because ACC is rare, it can be challenging to study, and treatment approaches are often complex. Your medical team will consider all these factors to give you the most accurate information about your specific prognosis and outlook, emphasizing that these are estimates and not certainties. Regular follow-up care is essential for monitoring the disease and managing any potential recurrence.

Symptoms

Symptoms of adrenocortical carcinoma (ACC) can vary widely depending on whether the tumor produces excess hormones or if its size causes pressure on nearby organs. Common signs include unexplained weight gain or loss, new or worsening high blood pressure, muscle weakness, and changes in body hair or menstrual cycles.

Many symptoms of ACC are caused by the overproduction of hormones by the tumor. For example, excess cortisol can lead to Cushing's syndrome, causing symptoms like weight gain in the face and trunk, thin skin, easy bruising, and muscle weakness. Excess androgens (male hormones) can cause increased facial and body hair, acne, and deepening of the voice in women, while excess estrogens (female hormones) can lead to breast enlargement in men. If the tumor produces too much aldosterone, it can cause high blood pressure (hypertension) and low potassium levels, leading to muscle weakness, cramps, and fatigue. Some tumors do not produce excess hormones (non-functional tumors). In these cases, symptoms often appear when the tumor grows large enough to press on nearby organs, causing abdominal pain, a feeling of fullness, or a lump that can be felt in the abdomen. Other general symptoms that may occur with ACC, regardless of hormone production, include unexplained weight loss, loss of appetite, and a general feeling of being unwell (malaise). Because these symptoms can be vague and mimic other conditions, ACC can sometimes be difficult to diagnose early.

Causes & risk factors

The exact causes of adrenocortical carcinoma (ACC) are largely unknown, and most cases occur without a clear reason. However, a small number of ACC cases are linked to inherited genetic syndromes. These syndromes increase a person's risk of developing various cancers, including ACC, but do not directly cause the cancer in everyone.

Most adrenocortical carcinomas are sporadic, meaning they develop without any known genetic cause or family history. Researchers are still working to understand the specific genetic changes that lead to ACC development in these cases. It is important to remember that having a risk factor does not mean you will definitely get ACC, and many people with ACC have no known risk factors. About 1 in 10 people (10%) with ACC have an inherited genetic syndrome that increases their risk. These syndromes include Li-Fraumeni syndrome, which is associated with a mutation in the TP53 gene; Multiple Endocrine Neoplasia type 1 (MEN1); Beckwith-Wiedemann syndrome; and Familial Adenomatous Polyposis (FAP). These conditions are rare, but if you have a family history of ACC or one of these syndromes, your doctor may recommend genetic counseling. Unlike some other cancers, there are no known lifestyle or environmental risk factors, such as smoking or diet, that have been definitively linked to an increased risk of developing ACC. The rarity of the disease makes it challenging to identify common risk factors, further emphasizing the importance of understanding genetic predispositions when present.

How it's diagnosed

Diagnosing adrenocortical carcinoma (ACC) typically involves a combination of imaging tests, blood and urine tests, and a biopsy. Imaging helps locate the tumor and assess its size and spread, while hormone tests check for overproduction. A biopsy, which involves taking a tissue sample, is usually needed to confirm the cancer diagnosis.

The diagnostic process often begins with imaging tests to visualize the adrenal glands and identify any tumors. Common imaging techniques include computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and positron emission tomography (PET) scans. These scans help doctors determine the tumor's size, its exact location, and whether it has spread to nearby lymph nodes or other organs. Blood and urine tests are crucial for checking hormone levels. Doctors will look for elevated levels of hormones such as cortisol, aldosterone, and androgens, which can indicate a functional ACC. These tests help differentiate ACC from benign (non-cancerous) adrenal tumors, which may also produce hormones but typically at lower levels or with different patterns. While imaging and hormone tests can strongly suggest ACC, a definitive diagnosis usually requires a biopsy. During a biopsy, a small tissue sample is removed from the tumor, often guided by imaging, and examined under a microscope by a pathologist. This examination confirms the presence of cancer cells and helps determine the specific type of adrenal tumor. In some cases, a biopsy may be performed after surgical removal of the tumor.

Treatment options

Treatment for adrenocortical carcinoma (ACC) is complex and often involves a multidisciplinary team of specialists. The primary treatment is usually surgery to remove the tumor, especially if it can be completely taken out. Other treatments, such as chemotherapy, radiation therapy, and targeted therapy, may be used alone or in combination, depending on the cancer's stage and characteristics.

For localized ACC, where the cancer has not spread beyond the adrenal gland, surgery is the most effective treatment and offers the best chance for a cure. The goal of surgery is to remove the entire tumor (complete resection) along with any affected surrounding tissue. If the tumor is large or has grown into nearby organs, a more extensive surgery may be necessary. If the cancer has spread or cannot be completely removed by surgery, other treatments become important. Chemotherapy, using drugs to kill cancer cells, is a common option. Mitotane is a specific chemotherapy drug often used for ACC, which works by suppressing adrenal hormone production and destroying adrenal cancer cells. It can be used after surgery to reduce the risk of recurrence or for advanced disease. Radiation therapy, which uses high-energy rays to kill cancer cells, may be used to control tumor growth, treat areas where the cancer has spread (metastasis), or relieve symptoms like pain. Targeted therapy drugs, which focus on specific weaknesses in cancer cells, are also being explored and used for ACC, offering more precise treatment options with potentially fewer side effects than traditional chemotherapy. Your treatment plan will be tailored to your specific situation.

Recovery & outlook

The recovery and outlook for adrenocortical carcinoma (ACC) vary significantly, primarily depending on the cancer's stage at diagnosis and the success of initial treatment. Generally, ACC found at an early stage and completely removed surgically has a better prognosis. However, ACC is known for its potential to recur, making long-term monitoring crucial for all patients.

For patients with localized ACC (Stage I or II) that can be completely removed by surgery, the 5-year survival rate can be about 60% to 80%. This means that about 6 to 8 out of 10 people are still alive five years after diagnosis. However, for more advanced stages, such as regional spread (Stage III) or distant spread (Stage IV), the 5-year survival rates are significantly lower, ranging from about 20% to 50% for regional disease and less than 10% to 20% for distant metastatic disease. It is important to understand that these survival rates are averages and do not predict any individual's outcome. Many factors influence these numbers, including the patient's overall health, the tumor's biological characteristics (such as its grade or how aggressive it appears under a microscope), and the response to treatment. Even after successful surgery, ACC has a high risk of coming back (recurrence), often within the first two years. Therefore, ongoing follow-up care is a critical part of recovery. This typically involves regular physical exams, blood tests to monitor hormone levels, and imaging scans (CT or MRI) to check for any signs of recurrence. Managing symptoms and side effects from treatment is also a key aspect of long-term recovery, often requiring a team of specialists to support your physical and emotional well-being.

When to see a doctor

You should see a doctor if you experience new or persistent symptoms that could suggest an adrenal gland issue, especially if they are unexplained or worsening. These include sudden weight changes, new high blood pressure, unexplained muscle weakness, or changes in body hair or menstrual cycles. Early detection is vital for improving the outlook for conditions like adrenocortical carcinoma.

Seek medical attention promptly if you notice any of the following: a new lump or pain in your abdomen, unexplained weight gain or loss, new or difficult-to-control high blood pressure, or persistent muscle weakness. These symptoms, while potentially related to many conditions, warrant investigation, especially if they appear suddenly or worsen over time. Women should also be alert to changes like increased facial or body hair, acne, or irregular menstrual periods that are not typical for them. Men might notice breast enlargement or tenderness. Children may experience early puberty or unusual growth patterns. These hormonal changes can be subtle but are important to discuss with a healthcare provider. While many of these symptoms can be caused by less serious conditions, it is crucial to have them evaluated by a doctor. Early diagnosis of adrenocortical carcinoma significantly improves treatment effectiveness and overall prognosis. Do not delay seeking medical advice if you have concerns about your health or notice any unusual symptoms.

Frequently asked questions

What is the average life expectancy for someone with adrenocortical carcinoma?

The average life expectancy for someone with adrenocortical carcinoma (ACC) varies greatly. It depends on the cancer's stage at diagnosis, whether it has spread, and how well it responds to treatment. For localized ACC, 5-year survival rates can be high, but for advanced stages, the outlook is more challenging. These are averages, and individual outcomes differ.

Can adrenocortical carcinoma be cured?

Adrenocortical carcinoma (ACC) can be cured, especially if it is detected at an early stage and completely removed through surgery. However, even after successful surgery, there is a risk of the cancer returning (recurrence). For advanced or metastatic ACC, a cure is less common, but treatments aim to control the disease and improve quality of life.

What factors affect the prognosis of ACC?

Several factors affect the prognosis of adrenocortical carcinoma (ACC). These include the stage of the cancer at diagnosis (how much it has spread), the tumor's size, whether the tumor can be completely removed surgically, and the tumor's biological characteristics (such as its grade or aggressiveness). The patient's overall health also plays a role.

Is adrenocortical carcinoma always aggressive?

Adrenocortical carcinoma (ACC) is generally considered an aggressive cancer. It has a tendency to grow quickly and can spread to other parts of the body. However, the degree of aggressiveness can vary between individual tumors, and early detection and treatment can significantly impact its course.

What is the role of mitotane in ACC treatment?

Mitotane is a specific chemotherapy drug often used in the treatment of adrenocortical carcinoma (ACC). It works by suppressing the adrenal gland's hormone production and directly destroying adrenal cancer cells. It can be used after surgery to reduce the risk of recurrence or as a treatment for advanced or metastatic disease.

How often do I need follow-up appointments after ACC treatment?

After treatment for adrenocortical carcinoma (ACC), regular and frequent follow-up appointments are crucial. These typically involve physical exams, blood tests to monitor hormone levels, and imaging scans (like CT or MRI) every few months, especially in the first few years. The exact schedule will be determined by your medical team based on your specific case and risk of recurrence.

Sources

• MedlinePlus — Adrenocortical Carcinoma Prognosis and Outlook
• Mayo Clinic — Adrenocortical Carcinoma Prognosis and Outlook
• Cochrane Library — Adrenocortical Carcinoma Prognosis and Outlook